AMILI

Private

SingaporeHealthcare & Life Scienceshttps://amili.asia

Last Round

Debt

May 29, 2023

Total Funding Raised

$10.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

AMILI is a biotechnology company that provides gut microbiome data insights, analytics, tests, and therapeutics, and operates Southeast Asia's first gut microbiome transplant bank.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Hardware Sales, Government Contracts

AI Layer

Infrastructure

Keywords

gut microbiome databasefecal microbiota transplantFMTmicrobiome analyticsAsian gut microbiomeat-home gut testgut microbiome transplant bankstool bankpersonalized probioticsstool test kitprecision medicinemicrobiome sequencinghealthcare analyticsbiotechnologypoop transplant

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AMILI Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

AMILI Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Debt	May 29, 2023
Series A	Jun 15, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Jeremy Lim

Chief Executive Officer

Executive Team

Manu Swarup

Chief Operating Officer

Executive Team

AMILI Investors

Notable investors and investment history

Investor	Rounds
SEEDS Capital	Series A
Blue7	Series A
East Ventures	Debt
Elang Mahkota Teknologi	Series A
Cercano Management	Series A
TVM Capital Healthcare	Series A
Pureland Group	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 10, 2026
Developing a precise nutrition program in collaboration with Google.
Feb 10, 2026
Collaborating on a personalized nutrition program for healthy living.

View all signals

AMILI Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

AMILI Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AMILI's valuation, stock price, and market status.

Firmographic Details

HeadquartersSingapore

Employee Range57

Year Founded2019

Last FundingMay 29, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.